The Effect of Pulmonary Rehabilitation on Bronchoscopic Volume Reduction Process Success
Primary Purpose
Emphysema, Pulmonary Rehabilitation, Bronchoscopic Lung Volume Reduction
Status
Completed
Phase
Not Applicable
Locations
Study Type
Interventional
Intervention
Pulmonary Rehabilitation
Standart care
Sponsored by
About this trial
This is an interventional treatment trial for Emphysema
Eligibility Criteria
Inclusion Criteria:
- Between the ages of 18-75
- Patients with a diagnosis of emphysema and bronchoscopic procedures
Exclusion Criteria:
• Patients who develop complications related to the procedure after bronchoscopic procedure.
Sites / Locations
Arms of the Study
Arm 1
Arm 2
Arm Type
Experimental
Active Comparator
Arm Label
Pulmonary Rehabilitation Group
Non-Pulmonary Rehabilitation Group
Arm Description
Optimal medication and clinical follow-up plus Pulmonary rehabiltation
Optimal medication and clinical follow-up
Outcomes
Primary Outcome Measures
Six minute walking test
The test was conducted in a 30-meter corridor in line with American Thoracic Society (ATS) guidelines. Patients were asked to walk as far as they can. Prior to and following the test, oxygen saturation, heart rate and Borg fatigue rating were measured, and the walking distance were recorded
Pulmonary Function Tests
PFTs were performed by using the Sensormedics model 2400 (Yorba Linda, CA, USA) spirometry device, and according to the American Thoracic Society (ATS) guidelines
Secondary Outcome Measures
Carbonmonoxide diffusion test
It will performed in the pulmonary function test laboratory using Cosmed Quark PFT (USA) with single-breath technique
Full Information
NCT ID
NCT04347044
First Posted
April 13, 2020
Last Updated
August 18, 2020
Sponsor
Istanbul Medipol University Hospital
1. Study Identification
Unique Protocol Identification Number
NCT04347044
Brief Title
The Effect of Pulmonary Rehabilitation on Bronchoscopic Volume Reduction Process Success
Official Title
The Effect of Pulmonary Rehabilitation on Bronchoscopic Volume Reduction Process Success
Study Type
Interventional
2. Study Status
Record Verification Date
April 2020
Overall Recruitment Status
Completed
Study Start Date
January 1, 2013 (Actual)
Primary Completion Date
August 18, 2020 (Actual)
Study Completion Date
August 18, 2020 (Actual)
3. Sponsor/Collaborators
Responsible Party, by Official Title
Principal Investigator
Name of the Sponsor
Istanbul Medipol University Hospital
4. Oversight
Studies a U.S. FDA-regulated Drug Product
No
Studies a U.S. FDA-regulated Device Product
No
5. Study Description
Brief Summary
The data of patients undergoing bronchoscopic volume reduction procedure will be analyzed retrospectively. Patients will be divided into two groups as patients with and without Pulmonary Rehabilitation before the procedure, and changes in functional levels of patients will be compared.
Detailed Description
The data of patients who underwent bronchoscopic volume reduction between January 2013 and March 2019 will be examined.
Patients will be divided into two groups as pulmonary rehabilitation applied (PR group) and not applied (Control group) before the procedure.
Changes in the parameters of initial and rehabilitation follow-up will be examined.
6. Conditions and Keywords
Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Emphysema, Pulmonary Rehabilitation, Bronchoscopic Lung Volume Reduction
7. Study Design
Primary Purpose
Treatment
Study Phase
Not Applicable
Interventional Study Model
Parallel Assignment
Masking
None (Open Label)
Allocation
Non-Randomized
Enrollment
80 (Actual)
8. Arms, Groups, and Interventions
Arm Title
Pulmonary Rehabilitation Group
Arm Type
Experimental
Arm Description
Optimal medication and clinical follow-up plus Pulmonary rehabiltation
Arm Title
Non-Pulmonary Rehabilitation Group
Arm Type
Active Comparator
Arm Description
Optimal medication and clinical follow-up
Intervention Type
Other
Intervention Name(s)
Pulmonary Rehabilitation
Intervention Description
Exercise training+ Optimal medication and clinical follow-up
Intervention Type
Other
Intervention Name(s)
Standart care
Intervention Description
Optimal medication and clinical follow-up
Primary Outcome Measure Information:
Title
Six minute walking test
Description
The test was conducted in a 30-meter corridor in line with American Thoracic Society (ATS) guidelines. Patients were asked to walk as far as they can. Prior to and following the test, oxygen saturation, heart rate and Borg fatigue rating were measured, and the walking distance were recorded
Time Frame
20 minutes
Title
Pulmonary Function Tests
Description
PFTs were performed by using the Sensormedics model 2400 (Yorba Linda, CA, USA) spirometry device, and according to the American Thoracic Society (ATS) guidelines
Time Frame
15 minutes
Secondary Outcome Measure Information:
Title
Carbonmonoxide diffusion test
Description
It will performed in the pulmonary function test laboratory using Cosmed Quark PFT (USA) with single-breath technique
Time Frame
15 minutes
10. Eligibility
Sex
All
Minimum Age & Unit of Time
18 Years
Maximum Age & Unit of Time
75 Years
Accepts Healthy Volunteers
No
Eligibility Criteria
Inclusion Criteria:
Between the ages of 18-75
Patients with a diagnosis of emphysema and bronchoscopic procedures
Exclusion Criteria:
• Patients who develop complications related to the procedure after bronchoscopic procedure.
12. IPD Sharing Statement
Plan to Share IPD
Undecided
Learn more about this trial
The Effect of Pulmonary Rehabilitation on Bronchoscopic Volume Reduction Process Success
We'll reach out to this number within 24 hrs